Concepedia

Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Hiroyuki Hanai, Takayuki Iida, Ken Takeuchi, Fumitoshi Watanabe, Yasuhiko Maruyama, Akira Andoh, Tomoyuki Tsujikawa, Y Fujiyama, Keiichi Mitsuyama, Michio Sata,

Clinical Gastroenterology and Hepatology · 2006 · 693 citations · 28 references

DOI

Concepts

References

28

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

, , +10

Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)

Sanjaya Singh, Bharat B. Aggarwal · Journal of Biological Chemistry · 1995 · 1.4K citations · Full text

, , +12

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Daniel Rachmilewitz · BMJ · 1989 · 1K citations · Full text

, , +15

Activation of nuclear factor κB in inflammatory bowel disease

Stefan Schreiber, Susanna Nikolaus, Jochen Hampe · Gut · 1998 · 747 citations · Full text

, , +17

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Claudia Wahl, Susanne Liptay, G. Adler et al. · Journal of Clinical Investigation · 1998 · 740 citations · Full text

, , +17